Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience.
- 1 May 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 7 (S1) , S17-S22
- https://doi.org/10.1002/ibd.3780070505
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Infliximab in Crohn's Disease: First Anniversary Clinical ExperienceAmerican Journal of Gastroenterology, 2000
- Long-term follow-up of patients treated with infliximab (anti-TNFa antibody) in clinical trialsGastroenterology, 2000
- Attenuation of response to multiple retreatment infliximab infusions for active Crohn's disease (CD): potential factors that minimize decreased responseGastroenterology, 2000
- Long Term Safety of InfliximabCanadian Journal of Gastroenterology and Hepatology, 2000
- Review article: safety of infliximab in clinical trialsAlimentary Pharmacology & Therapeutics, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Azathioprine and 6-Mercaptopurine in Crohn DiseaseAnnals of Internal Medicine, 1995
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994
- Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Gut, 1993